The use of focused cardiac ultrasound to screen for occult heart disease in asymptomatic cats

by Kerry A. Loughran, John E. Rush, Elizabeth A. Rozanski, Mark A. Oyama, Éva Larouche‐Lebel, Marc S. Kraus
Published 2019-09-01

Gut Dysbiosis and Its Associations with Gut Microbiota-Derived Metabolites in Dogs with Myxomatous Mitral Valve Disease

by Qinghong Li, Éva Larouche-Lebel, Kerry A. Loughran, Terry P. Huh, Jan S. Suchodolski, Mark A. Oyama
Published 2021-04-01

Circulating exosome microRNA associated with heart failure secondary to myxomatous mitral valve disease in a naturally occurring canine model

by Vicky K. Yang, Kerry A. Loughran, Dawn M. Meola, Christine M. Juhr, Kristen E. Thane, Airiel M. Davis, Andrew M. Hoffman
Published 2017-12-01

Plasma and tissue angiotensin‐converting enzyme 2 activity and plasma equilibrium concentrations of angiotensin peptides in dogs with heart disease

by Éva Larouche‐Lebel, Kerry A. Loughran, Mark A. Oyama, Phil F. Solter, Danielle S. Laughlin, Melissa D. Sánchez, Charles‐Antoine Assenmacher, Philip R. Fox, Ryan C. Fries
Published 2019-07-01